Handwriting Analysis in Movement Disorders.
- Sponsor
- Western University, Canada
- Study ID
- NCT06436287
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Movement Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Study Details
Movement disorders are a group of neurological conditions that cause problems with movement, either in the form of excessive, reduced, or slow movements. Some commonly known movement disorders include Parkinson disease, dystonia, ataxia, and Tourette syndrome. Multiple movement disorders have unique handwriting characteristics that can be measured using an inkless pen and a digitalized tablet. Handwriting is a complex skill that requires a combination of cognition, motor planning, and visuomotor integration. Handwriting deteriorates in patients with neurodegenerative diseases. This study aims to discern variations in the kinematics (movement patterns) involved in handwriting between individuals with movement disorders and healthy controls. Participants will be invited to carry out a series of handwriting tasks. The pen motions will be captured using an inkless pen and a digitizing tablet linked to a laptop. The entire set of tasks is designed to be completed within 30 minutes. The data will then be collected, processed, and analyzed utilizing a handwriting analysis software.
Key Dates
- First listed
- May 31, 2024
- Start date
- Jan 31, 2025
- Status verified
- Jan 2025
- Primary completion
- Jul 31, 2029
- Completion
- Jul 31, 2030
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: CasesDiagnosed with a movement disorder
- Arm: ControlHealthy controls
Primary Outcome Measure
Primary handwriting kinematic parameter (velocity) [ Time Frame: Day 1 ]
Central Contacts
- Aditya Murgai519-685-8500
Related Studies
- Botulinum Toxin for the Treatment of Involuntary Movement DisordersRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Neurophysiological, Behavioral, and Cognitive Networks in Movement DisordersRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tampa, Florida
- SLC13A5 Deficiency Natural History Study - Remote OnlyEnrolling By Invitation · TESS Research Foundation · Palo Alto, California